Browsing Tag
FDA IND clearance
3 posts
Why Hemispherian’s FDA-cleared GLIX1 trial could be a turning point for brain cancer therapy
Hemispherian gets FDA clearance for GLIX1 Phase 1 trial in glioblastoma. Find out how this novel therapy targets DNA repair to combat deadly brain tumors.
Rocket Pharmaceuticals receives FDA clearance to begin human trials for RP-A701 in treating BAG3-associated dilated cardiomyopathy
Rocket Pharmaceuticals earns FDA IND clearance for RP-A701, advancing gene therapy for rare BAG3-associated dilated cardiomyopathy. Trial begins in U.S.
Archeus Technologies receives FDA clearance for ART-101 to begin prostate cancer therapy trials in 2025
Archeus Technologies wins FDA IND clearance for ART-101, an alpha-emitting radiopharmaceutical therapy targeting PSMA in advanced prostate cancer.